Latest SARcode Bioscience Inc. Stories
DUBLIN, February 13, 2014 /PRNewswire/ -- - Shire expects similar Non GAAP earnings per ADS growth in 2014 - Shire (LSE: SHP, NASDAQ: SHPG) announces
BRISBANE, Calif., July 18, 2011 /PRNewswire/ -- SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing.
- totally perplexed and mixed up.